Deep veins thrombosis in children with blood diseases

Cover Page

Cite item

Full Text

Abstract

Background. Children and adolescents undergoing treatment in the hospital for blood diseases are at risk of thrombotic complications. However, to date no major studies of the prevalence of thrombosis in this category of patients have been conducted in Russia.
The objective: to determine the incidence of symptomatic and asymptomatic deep vein thrombosis (DVT), as well as their distribution by gender and age in children with various blood disorders.
Materials and methods. Medical records of 1962 patients, aged from 0 to 17 years, were retrospectively analyzed. All DVT cases were confirmed by visualization methods. The presence of thrombosis clinical signs detected during physical examination, allowed identifying symptomatic DVT.
Results. DVT was diagnosed in 429 patients; the symptomatic (n = 110) and asymptomatic (n = 337) DVT were considered as two independent groups with cases of thrombosis. The highest incidence of thrombotic complications was found in children with acute lymphoblastic leukemia (ALL) – 30.77 %, non-Hodgkin’s lymphomas – 22.58 %, other malignant blood disorders – 18.75 %, myeloid leukemia – 15.63 %, Hodgkin’s lymphoma – 16.50 %, histiocytosis – 12.5 %, aplastic anemia – 7.94 %, other leukemia – 7.14 %. Symptomatic episodes were more common in patients with lymphomas, especially non-Hodgkin’s, and ALL, while asymptomatic DVT were more common among children with ALL.
Conclusion. The DVT prevalence in children with blood disorders exceeds 20 %, most of them are asymptomatic thrombosis, while symptomatic DVT are much less common. Patients receiving treatment for lymphomas and ALL have the highest number of venous thrombotic complications. Further research is needed to address the need for primary thrombotic prophylaxis in children with blood disorders.

About the authors

P. A. Zharkov

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997

Author for correspondence.
Email: pavel.zharkov@fccho-moscow.ru
ORCID iD: 0000-0003-4384-6754
Russian Federation

D. S. Morozova

Lomonosov Moscow State University; 1 Leninskie Gory, Moscow 119991

Russian Federation

D. A. Gobadze

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997

ORCID iD: 0000-0001-7808-1347
Russian Federation

D. A. Evstratov

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997

ORCID iD: 0000-0003-2801-7421
Russian Federation

D. V. Fedorova

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997

ORCID iD: 0000-0003-4567-1871
Russian Federation

L. I. Zharikova

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997; Pirogov Russian National Research Medical University, Ministry of Health of Russia; 1 Ostrovityanova, Moscow 117997

Russian Federation

A. V. Pshonkin

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997

ORCID iD: 0000-0002-2057-2036
Russian Federation

G. A. Novichkova

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997

ORCID iD: 0000-0002-2322-5734
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36928 от  21.07.2009.